Table 1 DVH metrics for DeliDose, CliDose, and PreDose in Monaco TPS.

From: Evaluation of deliverable artificial intelligence-based automated volumetric arc radiation therapy planning for whole pelvic radiation in gynecologic cancer

Monaco DVH parameters

Structure name

DVH metric

PreDose

DeliDose

CliDose

P-value

(PreDose vs. DeliDose)

P-value

(DeliDose vs. CliDose)

P-value

(PreDose vs. CliDose)

  

Mean ± SD

Mean ± SD

Mean ± SD

   

Body

Dmax (%)

106.5 ± 0.1

109.7 ± 0.8

108.7 ± 0.5

< 0.001

0.014

< 0.001

PTV

D50% (%)

99.9 ± 0.0

100.0 ± 0.0

100.0 ± 0.2

0.001

0.582

0.001

 

D98% (%)

93.2 ± 0.5

93.8 ± 0.4

93.9 ± 0.4

0.011

0.623

0.005

 

D95% (%)

94.9 ± 0.4

95.5 ± 0.4

95.7 ± 0.4

0.008

0.256

0.002

 

D2% (%)

103.2 ± 0.3

104.4 ± 0.5

103.9 ± 0.3

< 0.001

0.021

0.001

OL_PTV_Bowel

Dmax (%)

106.5 ± 0.1

104.4 ± 0.8

105.0 ± 0.9

< 0.001

0.198

0.002

Rectum

V40Gy (%)

58.7 ± 15.6

57.9 ± 15.5

59.1 ± 15.4

0.791

0.850

0.791

 

V50Gy (%)

6.8 ± 5.1

10.0 ± 6.4

14.4 ± 7.3

0.212

0.307

0.019

 

Dmax (%)

105.4 ± 0.7

103.7 ± 0.6

104.0 ± 0.6

< 0.001

0.427

0.002

Bladder

V45Gy (%)

46.9 ± 10.1

51.2 ± 11.2

46.3 ± 10.0

0.385

0.307

0.850

 

Dmax (%)

106.3 ± 0.3

104.2 ± 1.0

104.8 ± 0.5

< 0.001

0.140

< 0.001

Bowel Bag

V40Gy (%)

23.1 ± 5.3

22.6 ± 5.4

23.9 ± 5.3

0.496

0.273

0.385

PelvicBones

V10Gy (%)

89.7 ± 2.3

88.1 ± 2.9

86.0 ± 2.1

0.273

0.064

0.006

 

V40Gy (%)

27.6 ± 2.6

28.6 ± 2.9

28.8 ± 3.0

0.345

0.940

0.326

Femoral Joint

V30Gy (%)

3.5 ± 2.6

3.9 ± 2.9

5.9 ± 4.6

0.734

0.345

0.241

  1. Dmax: maximal dose; D50%: dose administered to 50% of volume; D98%: dose administered to 98% of volume; D95%: dose administered to 95% of volume; D2%: dose administered to 2% of volume; PTV: planning target volume; OL_PTV_Bowel: common area of PTV and Bowel Bag.
Back to article page